NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network®(NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual need

Updated on: October 31,2023

NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network®(NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual need

Updated on:October 31,2023

Intensity of Consolidation Pre-Transplant Shows No Difference in Outcomes in Older AML

September 7, 2023Caroline SeymourNo difference in relapse-free survival or non–relapse mortality was seen with intensive vs non-intensive consolidation chemotherapy regimens prior to allogeneic hemato

Updated on: October 11,2023

Intensity of Consolidation Pre-Transplant Shows No Difference in Outcomes in Older AML

September 7, 2023Caroline SeymourNo difference in relapse-free survival or non–relapse mortality was seen with intensive vs non-intensive consolidation chemotherapy regimens prior to allogeneic hemato

Updated on:October 11,2023

Brain tumor research could help future precision medicine

byUniversity of BristolCredit: CC0 Public DomainNew research on brain tumors could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumors are the

Updated on: December 20,2023

Brain tumor research could help future precision medicine

byUniversity of BristolCredit: CC0 Public DomainNew research on brain tumors could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumors are the

Updated on:December 20,2023

Exploring the links between diet and cancer

Omer Yilmaz’s work on how diet influences intestinal stem cells could lead to new ways to treat or prevent gastrointestinal cancers.Anne Trafton|MIT News OfficePublication Date:May 25, 202

Updated on: October 11,2023

Exploring the links between diet and cancer

Omer Yilmaz’s work on how diet influences intestinal stem cells could lead to new ways to treat or prevent gastrointestinal cancers.Anne Trafton|MIT News OfficePublication Date:May 25, 202

Updated on:October 11,2023

Common genetic defect in prostate cancer inspires path to new anti-cancer drugs

byTemple UniversityCredit: CC0 Public DomainLike security screening to make sure nothing harmful makes its way into a crowded area, cells in the human body use checkpoints to control their growt

Updated on: December 20,2023

Common genetic defect in prostate cancer inspires path to new anti-cancer drugs

byTemple UniversityCredit: CC0 Public DomainLike security screening to make sure nothing harmful makes its way into a crowded area, cells in the human body use checkpoints to control their growt

Updated on:December 20,2023

Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Updated on: September 27,2024

Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Updated on:September 27,2024

Why don't T cells destroy solid tumors during immunotherapy?

byUniversity of North Carolina Health Care3-D image of a T cell experiencing cell stress: endoplasmic reticulum (green), mitochondria (purple). Credit: Elizabeth Hunt, UNC School of MedicineThe

Updated on: January 08,2024

Why don't T cells destroy solid tumors during immunotherapy?

byUniversity of North Carolina Health Care3-D image of a T cell experiencing cell stress: endoplasmic reticulum (green), mitochondria (purple). Credit: Elizabeth Hunt, UNC School of MedicineThe

Updated on:January 08,2024

Discovery New Biomarker for Cancer Stem Cells

Protein Linked to Tumor Survival and SpreadByLaurie Fickman713-743-8454n the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnor

Updated on: October 31,2023

Discovery New Biomarker for Cancer Stem Cells

Protein Linked to Tumor Survival and SpreadByLaurie Fickman713-743-8454n the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnor

Updated on:October 31,2023

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

September 20, 2023Ashling WahnerEarly lung-specific response to atezolizumab plus bevacizumab was associated with longer overall survival in patients with hepatocellular carcinoma with pulmonary metas

Updated on: October 10,2023

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

September 20, 2023Ashling WahnerEarly lung-specific response to atezolizumab plus bevacizumab was associated with longer overall survival in patients with hepatocellular carcinoma with pulmonary metas

Updated on:October 10,2023

Radiotherapy for hard-to-treat bladder cancer

byInstitute of Cancer ResearchCredit: Institute of Cancer ResearchMore targeted forms of radiotherapy can effectively treat bladder cancer which has spread to the lymph nodes of the pelvis, acco

Updated on: December 20,2023

Radiotherapy for hard-to-treat bladder cancer

byInstitute of Cancer ResearchCredit: Institute of Cancer ResearchMore targeted forms of radiotherapy can effectively treat bladder cancer which has spread to the lymph nodes of the pelvis, acco

Updated on:December 20,2023

Cilta-Cel Leads to High PFS Rates in Patients With Multiple Myeloma and Poor Prognostic Features

September 30, 2023Courtney FlahertyPatients with multiple myeloma exhibiting poor prognostic features, such as high-risk cytogenetics, soft-tissue plasmacytoma, ISS stage III disease, and triple-class

Updated on: October 10,2023

Cilta-Cel Leads to High PFS Rates in Patients With Multiple Myeloma and Poor Prognostic Features

September 30, 2023Courtney FlahertyPatients with multiple myeloma exhibiting poor prognostic features, such as high-risk cytogenetics, soft-tissue plasmacytoma, ISS stage III disease, and triple-class

Updated on:October 10,2023

Corrupt endothelial cells found to protect blood cancer cells from chemotherapy

byWeill Cornell Medical CollegePatient-derived-tumor-xenograft (PDX) as models of high-risk T-ALL patients. (A) Schematic representation of the generation and expansion of T-ALL PDX models. PB:

Updated on: December 21,2023

Corrupt endothelial cells found to protect blood cancer cells from chemotherapy

byWeill Cornell Medical CollegePatient-derived-tumor-xenograft (PDX) as models of high-risk T-ALL patients. (A) Schematic representation of the generation and expansion of T-ALL PDX models. PB:

Updated on:December 21,2023